![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, November 03, 2015 2:35:38 PM
Educational Post - Dilution
Authorized Shares,
has no bearing on the price.
The "Shares Authorized",
is not used in any fundamental of financial calculation,
to determine company value.
OTC companies only have two things,
stock for sale and stories of progress.
Dilution:
when the company moves shares from the A/S (authorized shares)
to the O/S (outstanding shares) or tradeable inventory,
for cash investments in the company.
This means there are more shares
at the same market price
and reduces the size of the EPS.
It doesn't reduce the price or value of the stock.
But many pennylanders think it does.
Dilution
doesn't change price, it changes EPS.
Creating loss in company value, not stock value.
Hardly 1 in 1000 OTC companies have an EPS to effect.
So, dilution can't effect their company value in the first place.
What's the value of no earnings, thus no EPS.
On the OTC, "dilution" is the best news one can hear !
Not only does it give the company a chance at growth,
it doesn't effect their EPS value one bit.
They have no EPS to effect.
Plus, every time VCs get there hands on large amounts of shares,
they buy a run, and we can trade for profits !
So, "dilution" is a win for the company,
a win for the Venture capital firm,
and a win for the educated pennyland trader,
on the OTC.
Stocks of many start-up companies,
bottom at the "Sub-penny" and "Triple 000" price levels,
before they begin their meteoric rise.
"Venture Capitalists"
like to buy the shares of these companies at these low levels.
Long Term Bullish Breakout Scan :
http://www.stockta.com/cgi-bin/screen.pl?cobrand=&price=&price=0.005&volume=&volume=&country=&alert=33&action=Display&orderTag=%20price&order=ASC
Recent VISM News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:30:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/20/2024 09:16:24 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/14/2024 09:20:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/14/2023 09:22:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/29/2023 01:28:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:30:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 09:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/15/2023 08:41:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 08:33:23 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM